Significats de active relapsing en anglès

Natalizumab is a new treatment option for patients with active relapsing-remitting multiple sclerosis.

Approved disease-modifying therapies may be incompletely effective in some patients with highly active relapsing disease and high risk of disability.

The firms said the National Institute for Health and Clinical Excellence had recommended Tysabri as a treatment for highly active relapsing remitting multiple sclerosis.

European authorities approved Gilenya last March for people with highly active relapsing-remitting multiple sclerosis (RRMS), the commonest form of the debilitating disease.